Evidence map›Paper›PMID 28814511›Full record

ArticleJournal of the American Society of Nephrology : JASN2017

Targeting Phospholipase D4 Attenuates Kidney Fibrosis.

Priyanka Trivedi, Ramya K Kumar, Ashwin Iyer, Sarah Boswell, Casimiro Gerarduzzi, Vivekkumar P Dadhania, Zach Herbert, Nikita Joshi, James P Luyendyk, Benjamin D Humphreys and 1 more

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer.International journal of molecular sciences · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. DGKα in Neutrophil Biology and Its Implications for Respiratory Diseases.International journal of molecular sciences · 2019
    Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Priyanka TrivediRenal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Ramya K KumarRenal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Ashwin IyerRenal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Sarah BoswellHarvard Program in Therapeutic Sciences, Harvard Medical School, Boston, Massachusetts.
Casimiro GerarduzziRenal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Vivekkumar P DadhaniaRenal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Zach HerbertMolecular Biology Core Facilities, Dana-Farber Cancer Institute, Boston, Massachusetts.
Nikita JoshiDepartment of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, Michigan.
James P LuyendykDepartment of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, Michigan.
Benjamin D HumphreysDivision of Nephrology, Washington University School of Medicine, St. Louis, Missouri; and.
Vishal S VaidyaRenal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; vvaidya@bwh.harvard.edu.
Brigham and Women's Hospital · USHarvard University · USMichigan State University · USDana-Farber Cancer Institute · USWashington University in St. Louis · US

Funding

TRANSLATIONAL PHARMACOLOGY COREP50GM107618 · NIGMS · HARVARD MEDICAL SCHOOL · PI GOLAN, DAVID E. · 2014 to 2018
$10.8M
Role of SMOC2 in Kidney FibrosisR01ES017543 · NIEHS · BRIGHAM AND WOMEN'S HOSPITAL · PI VAIDYA, VISHAL S. · 2011 to 2021
$3.9M
Novel anti-fibrotic mechanisms in chemical-induced liver injuryR01ES017537 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI LUYENDYK, JAMES P · 2009 to 2019
$3.6M
Role of SMOC2 in Kidney FibrosisR56ES017543 · NIEHS · BRIGHAM AND WOMEN'S HOSPITAL · PI VAIDYA, VISHAL S. · 2016 to 2016
$213k
NIEHS NIH HHS R01 ES017537NIEHS NIH HHS R01 ES017543NIEHS NIH HHS R56 ES017543NIGMS NIH HHS P50 GM107618
6 · The paper itself

Abstract

Phospholipase D4 (PLD4), a single-pass transmembrane glycoprotein, is among the most highly upregulated genes in murine kidneys subjected to chronic progressive fibrosis, but the function of PLD4 in this process is unknown. Here, we found PLD4 to be overexpressed in the proximal and distal tubular epithelial cells of murine and human kidneys after fibrosis. Genetic silencing of PLD4, either globally or conditionally in proximal tubular epithelial cells, protected mice from the development of fibrosis. Mechanistically, global knockout of PLD4 modulated innate and adaptive immune responses and attenuated the upregulation of the TGF-

Indexed as

AnimalsExtracellular MatrixFibrosisFolic AcidGene LibraryGene SilencingGlycoproteinsHEK293 CellsHumansImmune SystemKidneyKidney DiseasesMaleMiceMice, Inbred C57BLMice, KnockoutFolic AcidGlycoproteinsPhospholipase DReceptor, trkARNA, Small Interferingchronic kidney diseasefibrosisimmunologyTGF-beta

Identifiers

PMID28814511
PMCPMC5698063
OpenAlexW2750128033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.